Dina Malounda

Dina Malounda

Auto-generated profile, based on publicly available information

Dina Malounda

Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2023 in Science Advances
Verified
Journal Article
Closed access
DWDi Wu
Di Wu
DBDiego Baresch
Diego Baresch
CCColin Cook
Colin Cook
Zhichao MaZhichao Ma
Zhichao Ma
MDMengtong Duan
Mengtong Duan
MSMikhail G. Shapiro
Mikhail G. Shapiro
The ability to physically manipulate specific cells is critical for the fields of biomedicine, synthetic biology, and living materials. Ultrasound has the ability to manipulate cells with high spatiotemporal precision via acoustic radiation force (ARF). However, because most cells have similar acoustic properties, this capability is disconnected from cellular genetic programs. Here, we show that gas vesicles (GVs)—a unique class of gas-filled protein nanostructures—can serve as genetically encodable actuators for selective acoustic manipulation. Because of their lower density and higher compressibility relative to water, GVs experience strong ARF with opposite polarity to most other materials. When expressed inside cells, GVs invert the cells’ acoustic contrast and amplify the magnitude of their ARF, allowing the cells to be selectively manipulated with sound waves based on their genotype. GVs provide a direct link between gene expression and acoustomechanical actuation, opening a paradigm for selective cellular control in a broad range of contexts.

1 April 2020 in NeuroImage
Verified
Journal Article
Open access
DMDavid Maresca
David Maresca
TPThomas Payen
Thomas Payen
ALAudrey Lee-Gosselin
Audrey Lee-Gosselin
BLBill Ling
Bill Ling
DMDina Malounda
Dina Malounda
MSMikhail G. Shapiro
Mikhail G. Shapiro
Hemodynamic functional ultrasound imaging (fUS) of neural activity provides a unique combination of spatial coverage, spatiotemporal resolution and compatibility with freely moving animals. However, deep and transcranial monitoring of brain activity and the imaging of dynamics in slow-flowing blood vessels remains challenging. To enhance fUS capabilities, we introduce biomolecular hemodynamic enhancers based on gas vesicles (GVs), genetically encodable ultrasound contrast agents derived from buoyant photosynthetic microorganisms. We show that intravenously infused GVs enhance ultrafast Doppler ultrasound contrast and visually-evoked hemodynamic contrast in transcranial fUS of the mouse brain. This hemodynamic contrast enhancement is smoother than that provided by conventional microbubbles, allowing GVs to more reliably amplify neuroimaging signals.

27 February 2021 in Protein Science
Verified
Journal Article
Closed access
PDF file
PDPrzemysław Dutka
Przemysław Dutka
DMDina Malounda
Dina Malounda
LMLauren Ann Metskas
Lauren Ann Metskas
SCSongye Chen
Songye Chen
RHRobert C. Hurt
Robert C. Hurt
MSMikhail G. Shapiro
Mikhail G. Shapiro

14 June 2021 in Applied Physics Letters
Verified
Journal Article
Closed access
PDF file
CRClaire Rabut
Claire Rabut
DWDi Wu
Di Wu
BLBill Ling
Bill Ling
ZJZhiyang Jin
Zhiyang Jin
DMDina Malounda
Dina Malounda
MSMikhail G. Shapiro
Mikhail G. Shapiro
Ultrasound is playing an emerging role in molecular and cellular imaging thanks to new micro- and nanoscale contrast agents and reporter genes. Acoustic methods for the selective in vivo detection of these imaging agents are needed to maximize their impact in biology and medicine. Existing ultrasound pulse sequences use the nonlinearity in contrast agents' response to acoustic pressure to distinguish them from mostly linear tissue scattering. However, such pulse sequences typically scan the sample using focused transmissions, resulting in a limited frame rate and restricted field of view. Meanwhile, existing wide-field scanning techniques based on plane wave transmissions suffer from limited sensitivity or nonlinear artifacts. To overcome these limitations, we introduce an ultrafast nonlinear imaging modality combining amplitude-modulated pulses, multiplane wave transmissions, and selective coherent compounding. This technique achieves contrast imaging sensitivity comparable to much slower gold-standard amplitude modulation sequences and enables the acquisition of larger and deeper fields of view, while providing a much faster imaging framerate of 3.2 kHz. Additionally, it enables simultaneous nonlinear and linear image formation and allows concurrent monitoring of phenomena accessible only at ultrafast framerates, such as blood volume variations. We demonstrate the performance of this ultrafast amplitude modulation technique by imaging gas vesicles, an emerging class of genetically encodable biomolecular contrast agents, in several in vitro and in vivo contexts. These demonstrations include the rapid discrimination of moving contrast agents and the real-time monitoring of phagolysosomal function in the mouse liver.

12 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ZJZhiyang Jin
Zhiyang Jin
ALAnupama Lakshmanan
Anupama Lakshmanan
RZRuby Zhang
Ruby Zhang
TTTeresa A. Tran
Teresa A. Tran
CRClaire Rabut
Claire Rabut
MSMikhail G. Shapiro
Mikhail G. Shapiro
Calcium imaging has enabled major biological discoveries. However, the scattering of light by tissue limits the use of standard fluorescent calcium indicators in living animals. To address this limitation, we introduce the first genetically encoded ultrasonic reporter of calcium (URoC). Based on a unique class of air-filled protein nanostructures called gas vesicles, we engineered URoC to produce elevated nonlinear ultrasound signal upon binding to calcium ions. With URoC expressed in mammalian cells, we demonstrate noninvasive ultrasound imaging of calcium signaling in vivo during drug-induced receptor activation. URoC brings the depth and resolution advantages of ultrasound to the in vivo imaging of dynamic cellular function and paves the way for acoustic biosensing of a broader variety of biological signals.

29 April 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
ABAvinoam Bar-Zion
Avinoam Bar-Zion
ANAtousa Nourmahnad
Atousa Nourmahnad
DMDavid R. Mittelstein
David R. Mittelstein
SYSangjin Yoo
Sangjin Yoo
DMDina Malounda
Dina Malounda
MSMikhail G. Shapiro
Mikhail G. Shapiro
Recent advances in molecular engineering and synthetic biology have made it possible for biomolecular and cell-based therapies to provide highly specific disease treatment. However, both the ability to spatially target the action of such therapies, and their range of effects on the target tissue remain limited. Here we show that biomolecules and cells can be engineered to deliver potent mechanical effects at specific locations inside the body under the direction of focused ultrasound. This capability is based on gas vesicles, a unique class of air-filled protein nanostructures derived from buoyant photosynthetic microbes. We show that low-frequency ultrasound can convert these nanoscale biomolecules into micron-scale cavitating bubbles, as demonstrated with acoustic measurements and ultrafast optical microscopy. This allows gas vesicles targeted to cell-surface receptors to serve as remotely detonated cell-killing agents. In addition, it allows cells genetically engineered to express gas vesicles to be triggered with ultrasound to lyse and release therapeutic payloads. We demonstrate these capabilities in vitro , in cellulo , and in vivo . This technology equips biomolecular and cellular therapeutics with unique capabilities for spatiotemporal control and mechanical action.